Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference61 articles.
1. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes;Coca;Arch Intern Med,2012
2. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials;Boussageon;BMJ,2011
3. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease;Thomas;Nat Rev Nephrol,2016
4. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes;Papademetriou;Kidney Int,2014
5. Kidney disease and increased mortality risk in type 2 diabetes;Afkarian;JASN,2013
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV;Diabetes, Obesity and Metabolism;2024-09-02
2. Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors;Diabetes, Obesity and Metabolism;2024-07
3. Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin;JAMA Internal Medicine;2024-06-01
4. Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level;Journal of the American Heart Association;2024-05-07
5. The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout;Nature Reviews Rheumatology;2024-03-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3